References
- Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79(3):629–61. doi:https://doi.org/10.1021/acs.jnatprod.5b01055
- Zhang J, Onakpoya IJ, Posadzki P, Eddouks M. The safety of herbal medicine: from prejudice to evidence. Evid Based Complement Altern Med. 2015; 2015:316706. doi:https://doi.org/10.1155/2015/316706
- Variya BC, Bakrania AK, Patel SS. Emblica officinalis (Amla): a review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms. Pharmacol Res. 2016;111:180–200. doi:https://doi.org/10.1016/j.phrs.2016.06.013
- Singh S, Singh A, Joshi H. Standardization of maturity indices in Indian gooseberry (Emblica afficitlalis) under semi-arid conditions of Gujarat. Indian J Agric Sci. 2006;76 (10):591–5.
- Balasubramanian S, Ganesh D, Panchal P, Teimouri M, Narayana VS. GC-MS analysis of phytocomponents in the methanolic extract of Emblica officinalis Gaertn (Indian Gooseberry). J Chem Pharm Res. 2014;6(6):843–5.
- Chugh CA, Bharti D. Chemical characterization of antifungal constituents of Emblica officinalis. Allelopathy J. 2014;34(2):155–78.
- Antony B, Merina B, Sheeba V, Mukkadan J. Effect of standardized Amla extract on atherosclerosis and dyslipidemia. Indian J Pharm Sci. 2006;68(4):437–41. doi:https://doi.org/10.4103/0250-474X.27814
- Khan KH. Roles of Emblica officinalis in medicine—a review. Bot Res Int. 2009;2(4):218–28.
- Suryanarayana P, Saraswat M, Petrash JM, Reddy GB. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats. Mol Vis. 2007;13:1291–7.
- Fatima N, Pingali U, Muralidhar N. Study of pharmacodynamic interaction of Phyllanthus emblica extract with clopidogrel and ecosprin in patients with type II diabetes mellitus. Phytomedicine. 2014;21(5):579–85. doi:https://doi.org/10.1016/j.phymed.2013.10.024
- Sultana S, Ahmad S, Khan N, Jahangir T. Effect of Emblica officinalis (Gaertn) on CCl 4 induced hepatic toxicity and DNA synthesis in Wistar rats. Indian J Exp Biol. 2005;43(5):430–6.
- Zhang Y-J, Nagao T, Tanaka T, Yang C-R, Okabe H, Kouno I. Antiproliferative activity of the main constituents from Phyllanthus emblica. Biol Pharm Bull. 2004;27(2):251–5. doi:https://doi.org/10.1248/bpb.27.251
- Sharma R, Martins N, Kuca K, Chaudhary A, Kabra A, et al. Chyawanprash: a traditional Indian bioactive health supplement. Biomolecules. 2019;9(5):161. doi:https://doi.org/10.3390/biom9050161
- Ngamkitidechakul C, Jaijoy K, Hansakul P, Soonthornchareonnon N, Sireeratawong S. Antitumour effects of Phyllanthus emblica L.: induction of cancer cell apoptosis and inhibition of in vivo tumour promotion and in vitro invasion of human cancer cells. Phytother Res. 2010;24(9):1405–13. doi:https://doi.org/10.1002/ptr.3127
- Rajeshkumar N, Pillai MR, Kuttan R. Induction of apoptosis in mouse and human carcinoma cell lines by Emblica officinalis polyphenols and its effect on chemical carcinogenesis. J Exp Clin Cancer Res. 2003;22(2):201–12.
- Banu SM, Selvendiran K, Singh JPV, Sakthisekaran D. Protective effect of Emblica officinalis ethanolic extract against 7,12-dimethylbenz(a) anthracene (DMBA) induced genotoxicity in Swiss albino mice. Hum Exp Toxicol. 2004;23(11):527–31. doi:https://doi.org/10.1191/0960327104ht484oa
- Jeena KJ, Joy K, Kuttan R. Effect of Emblica officinalis, Phyllanthus amarus and Picrorhiza kurroa on N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Lett. 1999;136(1):11–6. doi:https://doi.org/10.1016/s0304-3835(98)00294-8
- Khandelwal S, Shukla L, Shanker R. Modulation of acute cadmium toxicity by Emblica officinalis fruit in rat. Indian J Exp Biol. 2002;40(5):564–70.
- Sancheti G, Jindal A, Kumari R, Goyal P. Chemopreventive action of emblica officinalis on skin carcinogenesis in mice. Asian Pac J Cancer Prev. 2005;6(2):197–201.
- Nandi P, Talukder G, Sharma A. Dietary chemoprevention of clastogenic effects of 3,4-benzo(a)pyrene by Emblica officinalis Gaertn. fruit extract. Br J Cancer. 1997;76(10):1279–83. doi:https://doi.org/10.1038/bjc.1997.548
- De A, De A, Papasian C, Hentges S, Banerjee S, Haque I, Banerjee SK. Emblica officinalis extract induces autophagy and inhibits human ovarian cancer cell proliferation, angiogenesis, growth of mouse xenograft tumors. PLoS One. 2013;8(8):e72748. doi:https://doi.org/10.1371/journal.pone.0072748
- Jose JK, Kuttan G, Kuttan R. Antitumour activity of Emblica officinalis. J Ethnopharmacol. 2001;75(2-3):65–9. doi:https://doi.org/10.1016/S0378-8741(00)00378-0
- De A, De A, Sharma R, Suo W, Sharma M. Sensitization of carboplatinum- and taxol-resistant high-grade serous ovarian cancer cells carrying p53, BRCA1/2 mutations by Emblica officinalis (Amla) via multiple targets. J Cancer. 2020;11(7):1927–39. doi:https://doi.org/10.7150/jca.36919
- Hazra B, Sarkar R, Biswas S, Mandal N. Comparative study of the antioxidant and reactive oxygen species scavenging properties in the extracts of the fruits of Terminalia chebula, Terminalia belerica and Emblica officinalis. BMC Complement Altern Med. 2010;10(1):20. doi:https://doi.org/10.1186/1472-6882-10-20
- Kumaran A, Karunakaran RJ. Nitric oxide radical scavenging active components from Phyllanthus emblica L. Plant Foods Hum Nutr. 2006;61(1):1–5. doi:https://doi.org/10.1007/s11130-006-0001-0
- Naik GH, Priyadarsini KI, Bhagirathi RG, Mishra B, Mishra KP, Banavalikar MM, Mohan H. In vitro antioxidant studies and free radical reactions of triphala, an ayurvedic formulation and its constituents. Phytother Res. 2005;19(7):582–6. doi:https://doi.org/10.1002/ptr.1515
- Pozharitskaya ON, Ivanova SA, Shikov AN, Makarov VG, Galambosi B. Separation and evaluation of free radical-scavenging activity of phenol components of green, brown, and black leaves of Bergenia crassifolia by using HPTLC-DPPH* method. J Sep Sci. 2007;30(15):2447–51. doi:https://doi.org/10.1002/jssc.200700178
- Shivananjappa MM, Joshi MK. Influence of Emblica officinalis aqueous extract on growth and antioxidant defense system of human hepatoma cell line (HepG2). Pharm Biol. 2012;50(4):497–505. doi:https://doi.org/10.3109/13880209.2011.618501
- Hari Kumar KB, Sabu MC, Lima PS, Kuttan R. Modulation of haematopoetic system and antioxidant enzymes by Emblica officinalis gaertn and its protective role against gamma-radiation induced damages in mice. J Radiat Res. 2004;45(4):549–55. doi:https://doi.org/10.1269/jrr.45.549
- Anilakumar K, Nagaraj N, Santhanam K. Reduction of hexachlorocyclohexane-induced oxidative stress and cytotoxicity in rat liver by Emblica officinalis gaertn. Indian J Exp Biol. 2007;45(5):450–4.
- Chakraborty D, Verma R. Ameliorative effect of Emblica officinalis aqueous extract on ochratoxin-induced lipid peroxidation in the kidney and liver of mice. Int J Occup Med Environ Health. 2010;23(1):63–73. doi:https://doi.org/10.2478/v10001-010-0009-4
- Maru GB, Ramchandani AG, Kumar G, Garg R. Curcumin-mediated cellular responses in chemical carcinogenesis: in vivo studies. In: Watson RR, Preedy VR, Eds., Bioactive foods and extracts. CRC Press; 2010. pp. 189–211.
- Maru GB, Hudlikar RR, Kumar G, Gandhi K, Mahimkar MB. Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: from experimental models to clinical trials. World J Biol Chem. 2016;7(1):88–99. doi:https://doi.org/10.4331/wjbc.v7.i1.88
- Kumar G, Pillare S, Maru G. Black tea polyphenols-mediated in vivo cellular responses during carcinogenesis. Mini Rev Med Chem. 2010;10(6):492–505. doi:https://doi.org/10.2174/138955710791384063
- Sharma N, Trikha P, Athar M, Raisuddin S. In vitro inhibition of carcinogen-induced mutagenicity by Cassia occidentalis and Emblica officinalis. Drug Chem Toxicol. 2000;23(3):477–84. doi:https://doi.org/10.1081/dct-100100129
- Sultana S, Ahmed S, Sharma S, Jahangir T. Emblica officinalis reverses thioacetamide‐induced oxidative stress and early promotional events of primary hepatocarcinogenesis. J Pharm Pharmacol. 2010;56(12):1573–9. doi:https://doi.org/10.1211/0022357044931
- Sharma N, Trikha P, Athar M, Raisuddin S. Inhibitory effect of Emblica officinalis on the in vivo clastogenicity of benzo[a]pyrene and cyclophosphamide in mice. Hum Exp Toxicol. 2000;19(6):377–84. doi:https://doi.org/10.1191/096032700678815945
- Reddy VD, Padmavathi P, Varadacharyulu N. Emblica officinalis protects against alcohol-induced liver mitochondrial dysfunction in rats. J Med Food. 2009;12(2):327–33. doi:https://doi.org/10.1089/jmf.2007.0694
- Niture SK, Rao US, Srivenugopal KS. Chemopreventative strategies targeting the MGMT repair protein: augmented expression in human lymphocytes and tumor cells by ethanolic and aqueous extracts of several Indian medicinal plants. Int J Oncol. 2006;29(5):1269–78. doi:https://doi.org/10.3892/ijo.29.5.1269
- Khan MTH, Lampronti I, Martello D, Bianchi N, Jabbar S, Choudhuri MSK, Datta BK, Gambari R. Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: effects on in vitro cell growth of human tumor cell lines. Int J Oncol. 2002;21(1):187–92. doi:https://doi.org/10.3892/ijo.21.1.187
- Zhu X, Wang J, Ou Y, Han W, Li H. Polyphenol extract of Phyllanthus emblica (PEEP) induces inhibition of cell proliferation and triggers apoptosis in cervical cancer cells. Eur J Med Res. 2013;18(1):46. doi:https://doi.org/10.1186/2047-783X-18-46
- Panchabhai T, Ambarkhane S, Joshi A, Samant B, Rege N. Protective effect of Tinospora cordifolia, Phyllanthus emblica and their combination against antitubercular drugs induced hepatic damage: an experimental study. Phytother Res. 2008;22(5):646–50. doi:https://doi.org/10.1002/ptr.2356
- Darnell JE. Transcription factors as targets for cancer therapy. Nat Rev Cancer. 2002;2(10):740–9. doi:https://doi.org/10.1038/nrc906
- Mahata S, Pandey A, Shukla S, Tyagi A, Husain SA, Das BC, Bharti AC. Anticancer activity of Phyllanthus emblica Linn. (Indian gooseberry): inhibition of transcription factor AP-1 and HPV gene expression in cervical cancer cells. Nutr Cancer. 2013;65(sup1):88–97. doi:https://doi.org/10.1080/01635581.2013.785008
- Wang HM-D, Fu L, Cheng CC, Gao R, Lin MY, Su HL, Belinda NE, Nguyen TH, Lin W-H, Lee PC, et al. Inhibition of LPS-Induced oxidative damages and potential anti-inflammatory effects of Phyllanthus emblica extract via down-regulating NF-κB, COX-2, and iNOS in RAW 264.7 cells. Antioxidants. 2019;8(8):270. doi:https://doi.org/10.3390/antiox8080270
- Asmawi M, Kankaanranta H, Moilanen E, Vapaatalo H. Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts. J Pharm Pharmacol. 1993;45(6):581–4. doi:https://doi.org/10.1111/j.2042-7158.1993.tb05605.x
- Dang G, Parekar R, Kamat S, Scindia A, Rege N. Antiinflammatory activity of Phyllanthus emblica, Plumbago zeylanica and Cyperus rotundus in acute models of inflammation. Phytother Res. 2011;25(6):904–8. doi:https://doi.org/10.1002/ptr.3345
- Singh D, Yadav E, Falls N, Kumar V, Singh M, Verma A. Phytofabricated silver nanoparticles of Phyllanthus emblica attenuated diethylnitrosamine-induced hepatic cancer via knock-down oxidative stress and inflammation. Inflammopharmacology. 2019;27(5):1037–54. doi:https://doi.org/10.1007/s10787-018-0525-6
- Wang C-C, Yuan J-R, Wang C-F, Yang N, Chen J, Liu D, Song J, Feng L, Tan X-B, Jia X-B, et al. Anti-inflammatory effects of Phyllanthus emblica L on benzopyrene-induced precancerous lung lesion by regulating the IL-1β/miR-101/Lin28B signaling pathway. Integr Cancer Ther. 2017;16(4):505–15. doi:https://doi.org/10.1177/1534735416659358
- Yahayo W, Supabphol A, Supabphol R. Suppression of human fibrosarcoma cell metastasis by Phyllanthus emblica extract in vitro. Asian Pac J Cancer Prev. 2013;14(11):6863–7. doi:https://doi.org/10.7314/apjcp.2013.14.11.6863
- Gopa B, Bhatt J, Hemavathi KG. A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin. Indian J Pharmacol. 2012;44(2):238. doi:https://doi.org/10.4103/0253-7613.93857
- Akhtar MS, Ramzan A, Ali A, Ahmad M. Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. Int J Food Sci Nutr. 2011;62(6):609–16. doi:https://doi.org/10.3109/09637486.2011.560565
- Chen T-S, Liou S-Y, Chang Y-L. Supplementation of Emblica officinalis (Amla) extract reduces oxidative stress in uremic patients. Am J Chin Med. 2009;37(01):19–25. doi:https://doi.org/10.1142/S0192415X09006680
- Tewari S, Grover S, Sharma RK, Singh G, Sharma A. Emblica officinalis irrigation as an adjunct to scaling and root planning: a randomized controlled clinical trial. J Dent Indones. 2018;25(1):15–23. doi:https://doi.org/10.14693/jdi.v25i1.1152
- Usharani P, Fatima N, Nizampatnam M. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study. Diabet Metab Synd Obes. 2013;6:275–84.
- Fatima N, Pingali U, Pilli R. Evaluation of Phyllanthus emblica extract on cold pressor induced cardiovascular changes in healthy human subjects. Pharmacogn Res. 2014;6(1):29–35. doi:https://doi.org/10.4103/0974-8490.122914
- Khanna S, Das A, Spieldenner J, Rink C, Roy S. Supplementation of a standardized extract from Phyllanthus emblica improves cardiovascular risk factors and platelet aggregation in overweight/class-1 obese adults. J Med Food. 2015;18(4):415–20. doi:https://doi.org/10.1089/jmf.2014.0178